Last update 01 Nov 2024

IL-12 x CD86 x HPV E6 x IL-2 x HPV E7

Basic Info

Related Targets
IL-12CD86HPV E6[+2]

Related

1
Drugs associated with IL-12 x CD86 x HPV E6 x IL-2 x HPV E7
SQZ-eAPC-HPV
Target
CD86 x HPV E6 x HPV E7 x IL-12 x IL-2
Mechanism
CD86 inhibitors [+4]
Active Org.-
Originator Org.
SQZ Biotechnologies Co.SQZ Biotechnologies Co.
Active Indication-
Inactive Indication
HPV16 positive solid tumors [+1]
Drug Highest PhaseDiscontinued
First Approval Ctry. / Loc.-
First Approval Date20 Jan 1800
1
Clinical Trials associated with IL-12 x CD86 x HPV E6 x IL-2 x HPV E7
NCT05357898 / TerminatedPhase 1/2
A Phase 1/2, First-in-Human, Multicenter, Open-Label Study of SQZ-eAPC-HPV as Monotherapy and in Combination With Immune Checkpoint Inhibitor(s) in Patients With HPV16+ Recurrent, Locally Advanced, or Metastatic Solid Tumors
100 Clinical Results associated with IL-12 x CD86 x HPV E6 x IL-2 x HPV E7
Login to view more data
100 Translational Medicine associated with IL-12 x CD86 x HPV E6 x IL-2 x HPV E7
Login to view more data
0 Patents (Medical) associated with IL-12 x CD86 x HPV E6 x IL-2 x HPV E7
Login to view more data

Analysis

Perform a panoramic analysis of this field.
login
or
view full example data
Perform a panoramic analysis of this field.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free